Celon Pharma SA (CLN) — Financial Flexibility Index
Celon Pharma SA (CLN) has a Financial Flexibility Index of 0.39x as of December 2025. Free cash flow of zł36.63 Million (operating CF zł36.63 Million minus capex zł0.00) represents 0% of total liabilities (zł94.21 Million). Also explore CLN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Celon Pharma SA Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Celon Pharma SA across 14 annual periods. Check CLN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Celon Pharma SA (2012–2025)
Year-by-year free cash flow to debt coverage for Celon Pharma SA. For the full company profile including market capitalisation, see CLN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | zł23.85 Million | zł23.85 Million | zł94.21 Million | ▲ +117.9% |
| 2024 | 0.12x | zł11.45 Million | zł-11.34 Million | zł98.59 Million | ▼ -41.3% |
| 2023 | 0.20x | zł24.50 Million | zł-8.31 Million | zł123.75 Million | ▼ -12.4% |
| 2022 | 0.23x | zł29.20 Million | zł-4.70 Million | zł129.29 Million | ▼ -59.4% |
| 2021 | 0.56x | zł85.30 Million | zł43.95 Million | zł153.14 Million | ▼ -11.9% |
| 2020 | 0.63x | zł170.07 Million | zł70.90 Million | zł268.97 Million | ▲ +54.4% |
| 2019 | 0.41x | zł59.90 Million | zł-5.05 Million | zł146.31 Million | ▼ -50.8% |
| 2018 | 0.83x | zł95.70 Million | zł28.24 Million | zł114.94 Million | ▲ +25.2% |
| 2017 | 0.66x | zł56.64 Million | zł25.30 Million | zł85.20 Million | ▼ -2.0% |
| 2016 | 0.68x | zł41.93 Million | zł20.65 Million | zł61.82 Million | ▼ -52.9% |
| 2015 | 1.44x | zł97.23 Million | zł52.37 Million | zł67.47 Million | ▲ +10.0% |
| 2014 | 1.31x | zł46.90 Million | zł24.36 Million | zł35.82 Million | ▲ +182.4% |
| 2013 | 0.46x | zł14.09 Million | zł8.45 Million | zł30.39 Million | ▼ -61.7% |
| 2012 | 1.21x | zł17.21 Million | zł12.87 Million | zł14.22 Million | — |